The role of complement in Alzheimer’s disease pathology

This publication has 151 references indexed in Scilit:

• Activation of the classical complement pathway by NMDA injection into the striatum of the neonatal rat
  Molecular Immunology, 1998
• Up-regulated expression of decay-accelerating factor (CD55) confers increased complement resistance to sprouting neural cells
  European Journal of Immunology, 1998
• Transgenic models to assess the pathogenic actions of cytokines in the central nervous system
  Molecular Psychiatry, 1997
• RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
  Nature, 1996
• Multivalent Binding of Complement Protein C1q to the Amyloid β-Peptide (Aβ) Promotes the Nucleation Phase of Aβ Aggregation
  Biochemical and Biophysical Research Communications, 1995
• Enhanced cytotoxicity of amyloid β-peptide by a complement dependent mechanism
  Neuroscience Letters, 1994
• Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in alzheimer's disease
  Biochemical and Biophysical Research Communications, 1992
• Acute phase proteins but not activated microglial cells are present in parenchymal deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type
  Neuroscience Letters, 1992
• Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family
  Neuroscience Letters, 1989
• Complement activation in amyloid plaques in Alzheimer’s dementia
  Virchows Archiv B Cell Pathology Including Molecular Pathology, 1988